Stay updated with breaking news from Belgian Transparency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulated Information Leuven, BELGIUM – January 17, 2024 – 7:00 PM CET Oxurion NV , a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
Regulated Information Leuven, BELGIUM – January 12, 2024 – 8:00 AM CET Oxurion NV , a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
Regulated Information Leuven, BELGIUM, Boston, MA, US – October 30, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a first transparency notification on October 27, 2023, from Atlas Special Opportuni
Regulated Information Leuven, BELGIUM, Boston, MA, US – October 20, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Regulated Information Leuven, BELGIUM, Boston, MA, US – September 27, 2023 – 7.00 PM CET Oxurion NV , a biopharmaceutical company developing next generation standard of care ophthalmic therapies,...